Determinants of Symptomatic Vulvovaginal Candidiasis among Human Immunodeficiency Virus Type 1 Infected Women in Rural KwaZulu-Natal, South Africa
Table 3
Determinants of symptomatic vulvovaginal candidiasis among HIV-infected women.
Independent variables
Coefficient
Standard error
Wald chi-square
OR (95% CI)
value
CD4+ T cell groups
<200 cells
4.1
0.971
17.847
60.3 (9–134.8)
<0.0001
200–349 cells
2.186
0.901
5.886
8.9 (1.5–17.36)
0.015
≥350 cells
Referent
1
Vaginal Flora (Nugent’s scores)
less than 7 (BV negative)
3.143
0.954
10.844
23.2 (3.6–50.13)
<0.001
≥7 (BV positive)
Referent
1
Therapy groups
Patients not receiving antiretroviral therapy
1.251
0.573
4.768
3.5 (1.1–10.7)
0.029
Patients on antiretroviral therapy
Referent
1
Constant
−3.13
0.904
11.981
<0.001
Adjusted for previous history of sexually transmitted infections (STIs), presence of current STIs, history of condom use, pregnancy, and presenting symptoms.